Sep 27, 2022, 09:31 AM by

Sep 27, 2022, 09:31 AM by

This transaction increases BioIVT's global network for collecting high-quality, disease-state biospecimens and extends its capabilities to deliver fresh biospecimens and produce cell products for drug and diagnostic development.

Sep 27, 2022, 01:00 AM by User Not Found

Bio-IT World | In the latest episode of Bio-IT World’s Trends from the Trenches podcast, host Stan Gloss, founder of BioTeam, gets an update from Fernanda Foertter, Voltron Data, about her AI experiences in the past few years and whether we’ve made any real progress.

Sep 23, 2022, 10:29 AM by

For further information, images, and interview opportunities, please contact Kristy Harmer at ramarketing: kristy.harmer@ramarketingpr.com | +44 (0)191 222 1242 | ramarketingpr.com | Twitter: @ramarketingpr | Facebook: /ramarketingpr | Linkedin: /ramarketing About Abzena Abzena provides the most complete set of solutions in integrated early discovery to mid-phase biotherapeutic and bioconjugation drug development and manufacturing in the biopharmaceutical industry. The company maintains resources around the world, with facilities in the US and UK. Abzena is owned by Welsh, Carson, Anderson & Stowe, one of the world’s leading private equity investors. For more information, please see www.abzena.com.

Sep 23, 2022, 10:24 AM by

Sep 23, 2022, 10:24 AM by

Sep 23, 2022, 10:17 AM by

Sep 23, 2022, 10:14 AM by

Sep 23, 2022, 10:10 AM by

Sep 23, 2022, 10:10 AM by

Sep 23, 2022, 10:07 AM by

Sep 23, 2022, 09:49 AM by

Sep 23, 2022, 01:00 AM by User Not Found

Bio-IT World | Since mid-2021, many papers have described actionable links between genome-wide association studies and specific diseases based on single-cell data. But one associated challenge that comes up repeatedly is the handling, storing, and analyzing of the abundant data that is now available.

Sep 22, 2022, 09:31 AM by

Sep 22, 2022, 09:30 AM by

Connect in Pharma provided a platform where key players in European pharma found innovative, patient-centric and sustainable solutions for strengthening the pharmaceutical supply chain.

Sep 22, 2022, 09:29 AM by

Sep 22, 2022, 09:28 AM by

Sep 22, 2022, 09:28 AM by

Sep 22, 2022, 09:28 AM by

Sep 22, 2022, 09:26 AM by

The newly signed document delivery distribution agreement will make Springer Nature article acquisition available to life science companies that license access to PubHive’s scientific workflow management platform